Sign in

CIK 0001010086

  • Accelerated filer

SIGA TECHNOLOGIES INC

Sign in to watch
Ticker
SIGA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
133864870
Phone
+1 212-672-9100
Business address
31 EAST 62ND STREET, NEW YORK, NY, 10065
Former names
SIGA PHARMACEUTICALS INC
  1. 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
  2. 4 Open-market sale Chief Executive Officer sold 20,000 shares at $1.21 ($24,200)
  3. 4 Exercise or conversion Executive VP & CFO acquired 19,584 shares (option exercise)
  4. 4 Exercise or conversion VP & Chief Scientific Officer acquired 18,750 shares (option exercise)
  5. 4 Exercise or conversion Executive VP & General Counsel acquired 12,500 shares (option exercise)
  6. 4 Open-market sale Chief Executive Officer sold 20,000 shares at $1.32 ($26,400)
  7. 4 Exercise or conversion Executive VP & General Counsel acquired 12,500 shares (option exercise)
  8. 4 Exercise or conversion Executive VP & CFO acquired 19,583 shares (option exercise)
  9. 4 Exercise or conversion VP & Chief Scientific Officer acquired 18,750 shares (option exercise)
  10. 4 Exercise or conversion Executive VP & General Counsel acquired 12,500 shares (option exercise)
  11. 4 Exercise or conversion VP & Chief Scientific Officer acquired 18,750 shares (option exercise)
  12. 4 Open-market sale Chief Executive Officer sold 25,000 shares at an average $1.43 ($35,786)
  13. 4 Exercise or conversion Executive VP & CFO acquired 19,583 shares (option exercise)
  14. 4 Open-market sale Executive VP & CFO sold 7,500 shares at $1.54 ($11,550)
  15. 4 Exercise or conversion Chief Executive Officer acquired 50,000 shares (option exercise)
  16. 4 Exercise or conversion VP & Chief Scientific Officer acquired 18,750 shares (option exercise)
  17. 4 Exercise or conversion Executive VP & CFO acquired 19,583 shares (option exercise)
  18. 4 Exercise or conversion Executive VP & General Counsel acquired 12,500 shares (option exercise)
  19. 4 Open-market sale VP & Chief Scientific Officer sold 40,000 shares at an average $1.62 ($64,765)
  20. 4 Open-market sale Chief Executive Officer sold 25,000 shares at an average $1.67 ($41,641)

Page 11 of 25 · 495 filings